Clinical Trials Browser

Interventional × RC48 antibody × 30 days × Clear all

NCT06003231 2026-06-01

A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2

Phase 2 Active not recruiting

GynecologicHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT07608224 2026-05-27

HOPE-07-MIBC

Phase 2/3 Not yet recruiting

Urinary Bladder Neoplasms